Cargando…

Molecular characterization of circulating tumor cells in lung cancer: moving beyond enumeration

Molecular characterization of tumor cells is a key step in the diagnosis and optimal treatment of lung cancer. However, analysis of tumor samples, often corresponding to small biopsies, can be difficult and does not accurately reflect tumor heterogeneity. Recent studies have shown that isolation of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lei, Dumenil, Coraline, Julié, Catherine, Giraud, Violaine, Dumoulin, Jennifer, Labrune, Sylvie, Chinet, Thierry, Emile, Jean-François, He, Biao, Giroux Leprieur, Etienne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752564/ https://www.ncbi.nlm.nih.gov/pubmed/29312651 http://dx.doi.org/10.18632/oncotarget.22651

Ejemplares similares

Clinical factors associated with early progression and grade 3–4 toxicity in patients with advanced non-small-cell lung cancers treated with nivolumab
por: Dumenil, Coraline, et al.
Publicado: (2018)

Role of antibiotic use, plasma citrulline and blood microbiome in advanced non-small cell lung cancer patients treated with nivolumab
por: Ouaknine Krief, Julia, et al.
Publicado: (2019)

Sequential ctDNA whole-exome sequencing in advanced lung adenocarcinoma with initial durable tumor response on immune checkpoint inhibitor and late progression
por: Giroux Leprieur, Etienne, et al.
Publicado: (2020)

Positive plasma cotinine during platinum-based chemotherapy is associated with poor response rate in advanced non-small cell lung cancer patients
por: Dacosta-Noble, Philippine, et al.
Publicado: (2019)

Baseline Hedgehog Pathway Activation and Increase of Plasma Wnt1 Protein Are Associated with Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer
por: Mehlman, Camille, et al.
Publicado: (2021)

Plasma Biomarkers Screening by Multiplex ELISA Assay in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors
por: Costantini, Adrien, et al.
Publicado: (2020)

Plasma Biomarkers and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: New Tools for Better Patient Selection?
por: Costantini, Adrien, et al.
Publicado: (2019)

Relapsing pneumonitis due to two distinct inhibitors of the MAPK/ERK pathway: report of a case
por: Giraud, Violaine, et al.
Publicado: (2015)

Circulating Tumor Cells, Enumeration and Beyond
por: Hou, Jian-Mei, et al.
Publicado: (2010)

Feasibility of spirometry in primary care to screen for COPD: a pilot study
por: Giraud, Violaine, et al.
Publicado: (2016)

High Circulating Sonic Hedgehog Protein Is Associated With Poor Outcome in EGFR-Mutated Advanced NSCLC Treated With Tyrosine Kinase Inhibitors
por: Takam Kamga, Paul, et al.
Publicado: (2021)

Corrigendum: High Circulating Sonic Hedgehog Protein Is Associated With Poor Outcome in EGFR-Mutated Advanced NSCLC Treated With Tyrosine Kinase Inhibitors
por: Takam Kamga, Paul, et al.
Publicado: (2022)

Paradoxical worsening of hypoxemia in a patient treated by noninvasive positive pressure ventilation for obesity hypoventilation syndrome with concomitant obstructive sleep apnea: a case report
por: de Picciotto, Carole, et al.
Publicado: (2017)

Old Sonic Hedgehog, new tricks: a new paradigm in thoracic malignancies
por: Giroux Leprieur, Etienne, et al.
Publicado: (2018)

Impact of Waiting Response Evaluation to First-Line Systemic Therapy before Considering Local Ablative Therapy in Metastatic Non-Small-Cell Lung Cancer
por: Belaidi, Lahcene, et al.
Publicado: (2023)

Beyond Enumeration: Functional and Computational Analysis of Circulating Tumor Cells to Investigate Cancer Metastasis
por: Castro-Giner, Francesc, et al.
Publicado: (2018)

Hedgehog Signaling in Lung Cancer: From Oncogenesis to Cancer Treatment Resistance
por: Giroux-Leprieur, Etienne, et al.
Publicado: (2018)

Beyond Equi-joins: Ranking, Enumeration and Factorization
por: Tziavelis, Nikolaos, et al.
Publicado: (2021)

Retracing Circulating Tumour Cells for Biomarker Characterization after Enumeration
por: Frandsen, Anders S., et al.
Publicado: (2015)

Bilateral Field Advantage in Visual Enumeration
por: Delvenne, Jean-François, et al.
Publicado: (2011)

Spotlight on crizotinib in the first-line treatment of ALK-positive advanced non-small-cell lung cancer: patients selection and perspectives
por: Leprieur, Etienne Giroux, et al.
Publicado: (2016)

Acute generalized exanthematous pustulosis caused by gemcitabine after nivolumab in metastatic lung adenocarcinoma followed by a dramatic tumor response: A case report
por: Magdelaine, Pierre, et al.
Publicado: (2022)

Detection and enumeration of circulating tumor cells based on their invasive property
por: Wang, Haizhen, et al.
Publicado: (2015)

Preclinical characterization of therapeutic antibodies targeted at the carboxy-terminus of Sonic hedgehog
por: Tolani, Bhairavi, et al.
Publicado: (2018)

Method validation of circulating tumour cell enumeration at low cell counts
por: Cummings, Jeffrey, et al.
Publicado: (2013)

2343: Enumeration of circulating tumor cells for monitoring cancer treatment response
por: Ignacio Varillas, Jose, et al.
Publicado: (2018)

Graphical enumeration
por: Harary, Frank, et al.
Publicado: (1973)

An Introduction to Enumeration
por: Camina, Alan, et al.
Publicado: (2011)

Combinatorial Enumeration
por: Goulden, Ian P, et al.
Publicado: (2004)

Collective Enumeration
por: Bahrami, Bahador, et al.
Publicado: (2012)

Beyond Circulating Tumor Cell Enumeration: Cell-Based Liquid Biopsy to Assess Protein Biomarkers and Cancer Genomics Using the RareCyte(®) Platform
por: Kaldjian, Eric P., et al.
Publicado: (2022)

Moving beyond MTBE.
por: Tenenbaum, D J
Publicado: (2000)

Moving beyond COVID
por: Tandon, Rajiv
Publicado: (2022)

Moving beyond Titers
por: Brooks, Benjamin D., et al.
Publicado: (2022)

Moving beyond MARCO
por: Rosa, Nicholas, et al.
Publicado: (2023)

Successful pulmonary arterial embolization followed by curative surgery for a lepidic predominant lung adenocarcinoma with severe hypoxemia
por: Sebane, Louise, et al.
Publicado: (2018)

Fourier ptychographic microscopy for filtration-based circulating tumor cell enumeration and analysis
por: Williams, Anthony, et al.
Publicado: (2014)

Enumeration And Characterization Of Circulating Tumor Cells And Its Application In Advanced Gastric Cancer
por: Cheng, Boran, et al.
Publicado: (2019)

Circulating Tumor Cells from Enumeration to Analysis: Current Challenges and Future Opportunities
por: Yang, Yu-Ping, et al.
Publicado: (2021)

Editorial: Emerging Biomarkers for NSCLC: Recent Advances in Diagnosis and Therapy
por: Malapelle, Umberto, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p8ecd9hsuu04thpts41rhp4d39